KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Other financing activities (2017 - 2021)

Twist Bioscience (TWST) has disclosed Other financing activities for 4 consecutive years, with -$2.6 million as the latest value for Q4 2021.

  • On a quarterly basis, Other financing activities fell 6.14% to -$2.6 million in Q4 2021 year-over-year; TTM through Dec 2021 was -$11.0 million, a 243.76% decrease, with the full-year FY2021 number at -$10.8 million, down 348.12% from a year prior.
  • Other financing activities was -$2.6 million for Q4 2021 at Twist Bioscience, up from -$2.6 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $1.4 million in Q1 2018 to a low of -$3.3 million in Q1 2021.
  • A 4-year average of -$1.1 million and a median of -$773000.0 in 2020 define the central range for Other financing activities.
  • Biggest YoY gain for Other financing activities was 6.14% in 2021; the steepest drop was 450.22% in 2021.
  • Twist Bioscience's Other financing activities stood at $470000.0 in 2017, then dropped by 7.66% to $434000.0 in 2018, then crashed by 655.3% to -$2.4 million in 2020, then dropped by 6.14% to -$2.6 million in 2021.
  • Per Business Quant, the three most recent readings for TWST's Other financing activities are -$2.6 million (Q4 2021), -$2.6 million (Q3 2021), and -$2.5 million (Q2 2021).